We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Groupe Crit | EU:CEN | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.60 | -0.81% | 73.60 | 73.20 | 73.60 | 74.40 | 73.60 | 74.00 | 1,801 | 16:30:00 |
RNS Number:9064Q CeNeS Pharmaceuticals PLC 14 October 2003 CENES PHARMACEUTICALS PLC ("the Company") HOLDING IN COMPANY The Company was informed on 14th October 2003 that Marlborough Fund Managers Limited, which did have a holding of over 3 per cent., has now sold part of its holding reducing the total holding to 2.13 per cent. of the total issued shares. Marlborough Fund Managers Limited now has a holding of 4.5 million shares registered as HSBC Global Custody Nominees a/c 764685. Further information Neil Clark, CeNeS Pharmaceuticals plc 01223 266 466 This information is provided by RNS The company news service from the London Stock Exchange END HOLUSUBRONRRAAA
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions